1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Activation of Estradiol-Positive Feedback at Puberty: Estradiol Sensitizes the LHRH-Releasing System at Two Different Biochemical Steps

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Experiments were performed to examine whether estradiol (E<sub>2</sub>) can influence some of the intraneuronal mechanisms involved in luteinizing hormone-releasing hormone (LHRH) release during the onset of puberty in the female rat. The capacity of median eminence (ME) nerve terminals to secrete LHRH, as determined by both their basal release of LHRH and by their response to prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) in vitro, increased significantly during the juvenile-early peripubertal periods of development (postnatal days 22–34). Ovariectomy (OVX) on day 22 led to a striking reduction in LHRH response to PGE2 on day 34. E<sub>2</sub> administered via s.c. Silastic capsules, at a dose that reproduces juvenile serum E<sub>2</sub> levels, restored the response. Simulation of first proestrous serum E2 levels in late juvenile (28-day-old) female rats enhanced both the sensitivity and the responsivenes of LHRH-containing terminals to PGE<sub>2</sub>. Furthermore, E<sub>2</sub> enhanced the sensitivity and the responsiveness of LHRH terminals to norepinephrine (NE). This effect appeared to be related to both the increased LHRH response to PGE<sub>2</sub> and an enhanced sensitivity of the PGE<sub>2</sub>-synthesizing pathway to NE. This is because MEs from E2-treated rats showed a marked increase in PGE<sub>2</sub> release in response to a NE concentration which was barely effective in untreated controls. It is suggested that one of the mechanisms by which E<sub>2</sub> activates the first preovulatory discharge of LHRH release in the female rat is by facilitating the occurrence of two different but sequentially related biochemical events: the stimulation of PGE<sub>2</sub> formation by NE and the enhancement of LHRH release by PGE<sub>2</sub>. In addition, it appears that maintenance of LHRH responsiveness to PGE<sub>2</sub>, which has been implicated as an obligatory component of NE-induced LHRH release, is E=-dependent.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1986
          1986
          01 April 2008
          : 43
          : 2
          : 259-265
          Affiliations
          Department of Physiology, University of Texas Health Science Center, Dallas, Tex., USA
          Article
          124535 Neuroendocrinology 1986;43:259–265
          10.1159/000124535
          3523279
          © 1986 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 7
          Categories
          Original Paper

          Comments

          Comment on this article